VANCOUVER, British Columbia, Aug. 16, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms for transformational human experiences, has received permission from Health Canada to manufacture and distribute…


Previous articleatai Life Sciences Reports Second Quarter 2022 Financial Results & Business Update
Next articlePT347 – Christopher Koddermann – Rescheduling Psilocybin, Patents and IP, and The Entourage Effect